Amy Grogg

Amy L. Grogg, PharmD and Vice President, leads the Reimbursement and Value consulting teams. Dr. Grogg partners with strategic account management teams to appropriately and effectively disseminate results of outcomes studies to external customers to aid in formulary and reimbursement decisions. She is the current chair of the Institutional Council for the International Society of Pharmacoeconomics and Outcomes Research. 

Dr. Grogg has been involved in more than 150 unique research studies and strategic marketing engagements. Her work in the pharmaceutical industry has included pharmacoeconomics, quality of life, and outcomes management research as well as presentations and publications for developmental and marketed products in hypercholesterolemia, oncology, analgesia, neurology, osteoporosis, pain management, psychiatry, neurology, gastroenterology, and many other therapeutic areas.

Prior to joining Xcenda, Dr. Grogg held various internal and regional positions within the Outcomes Research group at Janssen Pharmaceutica. She most recently led the Outcomes Research and Medical Informatics groups responsible for all health economic, quality of life, and patient-reported outcomes research studies as well as statistical analysis support for Medical Affairs activities for all marketed products from Janssen Pharmaceutica in the United States. Dr. Grogg was a member of the Medical Affairs Management Team, Chairman of the J&J Global Health Economics and Outcomes Research Council, and Chairman of the Janssen Women’s Leadership Initiative. 

Dr. Grogg received her Doctor of Pharmacy from Mercer University, Southern School of Pharmacy and completed a clinical practice residency at Hamot Medical Center in Erie, PA. She also completed a 2-year fellowship in pharmacoeconomics at Sandoz Pharmaceuticals Corporation and the University of South Carolina.
« Back